SG11201500157TA - Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1 r,5s) -3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide - Google Patents
Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1 r,5s) -3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamideInfo
- Publication number
- SG11201500157TA SG11201500157TA SG11201500157TA SG11201500157TA SG11201500157TA SG 11201500157T A SG11201500157T A SG 11201500157TA SG 11201500157T A SG11201500157T A SG 11201500157TA SG 11201500157T A SG11201500157T A SG 11201500157TA SG 11201500157T A SG11201500157T A SG 11201500157TA
- Authority
- SG
- Singapore
- Prior art keywords
- azepino
- cyclopropa
- tetrahydrobenzo
- dimethylsulfamoyl
- diazabicyclo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/08—Saturated compounds containing ether groups, groups, groups, or groups
- C07C62/10—Saturated compounds containing ether groups, groups, groups, or groups with a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds
- C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261672905P | 2012-07-18 | 2012-07-18 | |
PCT/US2013/050640 WO2014014885A1 (fr) | 2012-07-18 | 2013-07-16 | Nouveaux procédés et intermédiaires pour la préparation de |(4bs,5ar)-12-cyclohexyl-n-(n,n-diméthylsulfamoyl)-3-|méthoxy-5a-((1r,5s)-3-méthyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,|6-tétra- hydrobenzo[3,4]cyclopropa[5,6]azépino[1,2-a]indole-9-carboxamide |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201500157TA true SG11201500157TA (en) | 2015-03-30 |
Family
ID=48874561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201500157TA SG11201500157TA (en) | 2012-07-18 | 2013-07-16 | Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1 r,5s) -3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide |
Country Status (16)
Country | Link |
---|---|
US (1) | US9556204B2 (fr) |
EP (2) | EP2875030B1 (fr) |
JP (1) | JP6306002B2 (fr) |
KR (1) | KR20150038122A (fr) |
CN (1) | CN104640870A (fr) |
AU (1) | AU2013290402A1 (fr) |
BR (1) | BR112015000714A2 (fr) |
CA (1) | CA2879398A1 (fr) |
EA (1) | EA025391B1 (fr) |
ES (1) | ES2604781T3 (fr) |
HK (1) | HK1210770A1 (fr) |
IL (1) | IL236708A0 (fr) |
IN (1) | IN2015DN00625A (fr) |
MX (1) | MX2015000563A (fr) |
SG (1) | SG11201500157TA (fr) |
WO (1) | WO2014014885A1 (fr) |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02501388A (ja) | 1987-09-23 | 1990-05-17 | チバ ― ガイギー アクチエンゲゼルシャフト | 複素環式化合物 |
US7223785B2 (en) * | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7098231B2 (en) * | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7153848B2 (en) * | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
US7399758B2 (en) * | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
CN101443336B (zh) * | 2006-05-17 | 2012-07-04 | 百时美施贵宝公司 | 环丙基稠合的[吲哚]并[苯并氮杂*]hcv ns5b抑制剂 |
US7456166B2 (en) * | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7517872B2 (en) * | 2007-02-22 | 2009-04-14 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
JP5211078B2 (ja) * | 2007-03-13 | 2013-06-12 | ブリストル−マイヤーズ スクイブ カンパニー | シクロプロピル縮合インドロベンズアゼピンhcvns5b阻害剤 |
US7547690B2 (en) * | 2007-03-14 | 2009-06-16 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US7538102B2 (en) * | 2007-03-14 | 2009-05-26 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US7652004B2 (en) * | 2007-08-09 | 2010-01-26 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
KR20100108341A (ko) * | 2007-11-20 | 2010-10-06 | 브리스톨-마이어스 스큅 컴퍼니 | 시클로프로필 융합된 인돌로벤즈아제핀 hcv ns5b 억제제 |
US8124601B2 (en) * | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US8129367B2 (en) * | 2007-11-21 | 2012-03-06 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US8133884B2 (en) * | 2008-05-06 | 2012-03-13 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
-
2013
- 2013-07-16 EP EP13740485.1A patent/EP2875030B1/fr not_active Not-in-force
- 2013-07-16 CN CN201380048089.2A patent/CN104640870A/zh active Pending
- 2013-07-16 JP JP2015523175A patent/JP6306002B2/ja not_active Expired - Fee Related
- 2013-07-16 EA EA201590239A patent/EA025391B1/ru not_active IP Right Cessation
- 2013-07-16 MX MX2015000563A patent/MX2015000563A/es unknown
- 2013-07-16 EP EP16172744.1A patent/EP3091022A3/fr not_active Withdrawn
- 2013-07-16 AU AU2013290402A patent/AU2013290402A1/en not_active Abandoned
- 2013-07-16 IN IN625DEN2015 patent/IN2015DN00625A/en unknown
- 2013-07-16 KR KR20157004193A patent/KR20150038122A/ko not_active Application Discontinuation
- 2013-07-16 SG SG11201500157TA patent/SG11201500157TA/en unknown
- 2013-07-16 WO PCT/US2013/050640 patent/WO2014014885A1/fr active Application Filing
- 2013-07-16 ES ES13740485.1T patent/ES2604781T3/es active Active
- 2013-07-16 BR BR112015000714A patent/BR112015000714A2/pt not_active Application Discontinuation
- 2013-07-16 US US14/414,475 patent/US9556204B2/en not_active Expired - Fee Related
- 2013-07-16 CA CA2879398A patent/CA2879398A1/fr not_active Abandoned
-
2015
- 2015-01-13 IL IL236708A patent/IL236708A0/en unknown
- 2015-11-19 HK HK15111403.1A patent/HK1210770A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2879398A1 (fr) | 2014-01-23 |
EA025391B1 (ru) | 2016-12-30 |
IN2015DN00625A (fr) | 2015-06-26 |
MX2015000563A (es) | 2015-08-06 |
EP3091022A3 (fr) | 2016-12-14 |
WO2014014885A1 (fr) | 2014-01-23 |
US9556204B2 (en) | 2017-01-31 |
JP6306002B2 (ja) | 2018-04-04 |
US20150133654A1 (en) | 2015-05-14 |
KR20150038122A (ko) | 2015-04-08 |
CN104640870A (zh) | 2015-05-20 |
EP2875030B1 (fr) | 2016-10-26 |
AU2013290402A1 (en) | 2015-03-05 |
JP2015528008A (ja) | 2015-09-24 |
EP3091022A2 (fr) | 2016-11-09 |
EP2875030A1 (fr) | 2015-05-27 |
IL236708A0 (en) | 2015-02-26 |
ES2604781T3 (es) | 2017-03-09 |
BR112015000714A2 (pt) | 2017-06-27 |
EA201590239A1 (ru) | 2015-04-30 |
HK1210770A1 (en) | 2016-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013077921A3 (fr) | Pyrazolo[3,4-d]pyrimidines substituées et utilisations de celles-ci | |
PT2794611T (pt) | Pirazolo[1,5-a]pirimidinas como agentes antivirais | |
HK1256751A1 (zh) | [1,2,4]三唑並[1,5-a]嘧啶-7-基化合物 | |
AP3751A (en) | Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines | |
PH12014501258A1 (en) | Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof | |
EP2760430A4 (fr) | Traitement pour réduire l'aspect dégarni des cheveux | |
ZA201208894B (en) | Process for the preparation of 5-substituted-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amines | |
PT2734536T (pt) | Processo para a preparação de estetrol | |
EP2739627A4 (fr) | Composés 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1h)-one et utilisation en tant qu'inhibiteurs de lp-pla2 | |
IN2014KN01491A (fr) | ||
IL274047B (en) | Compounds for the treatment of blocking myelin regeneration in diseases associated with the expression of the envelope protein herv-w | |
HK1215248A1 (zh) | 被取代的吡唑並 嘧啶化合物、其製備及作為σ受體配體的用途 | |
GB201107985D0 (en) | Process | |
EP2778168A4 (fr) | Composé de pyrrolopyrroledione-thiophènequinone, son procédé de préparation et son utilisation | |
ZA201500865B (en) | Process for the preparation of sitagliptin and intermediate compounds | |
HK1198441A1 (en) | Pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma ligands [34-d] | |
SG11201408703YA (en) | Integrated process for the preparation of olefins | |
IL236808B (en) | Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one | |
IL236708A0 (en) | New methods and intermediates for the preparation of -(124-(5ar,bs-cyclohexyl-n,n)-n-dimethylsulfamoyl)-3-methoxy-3-(5s,1r))-5a-methyl-8,3-diazabicyclo[3.2 .1]octane-8-carbonyl)b4,5,a5,6-tetrahydrobenzo[3,4]cyclopropa[6,5]azepino[a-2,1]indole-9-carboxamide | |
IL232036A0 (en) | A new process for the preparation of acylguanidines and acylthioureas | |
SG11201400090UA (en) | Process for the preparation of olefins | |
EP2794609A4 (fr) | Produits réactionnels de dérivés stannylique de naphtalènediimides avec des composés de rylène | |
PT2702045T (pt) | Método inovador para a preparação de etravirina | |
PL393991A1 (pl) | Sposób wytwarzania kompozytowego katalizatora do niskotemperaturowego rozkładu podtlenku azotu | |
SG11201400091XA (en) | Process for the preparation of olefins |